SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
");background-position:center;background-size:19px 19px;background-repeat:no-repeat;background-color:var(--button-bg-color);padding:0;width:var(--form-elem-height);height:var(--form-elem-height);font-size:0;}:is(.js-newsletter-wrapper, .newsletter_bar.newsletter-wrapper) .widget__body:has(.response:not(:empty)) :is(.widget__headline, .widget__subheadline, #mc_embed_signup .mc-field-group, #mc_embed_signup input[type="submit"]){display:none;}:is(.grey_newsblock .newsletter-wrapper, .newsletter-wrapper) #mce-responses:has(.response:not(:empty)){grid-row:1 / -1;grid-column:1 / -1;}.newsletter-wrapper .widget__body > .snark-line:has(.response:not(:empty)){grid-column:1 / -1;}:is(.grey_newsblock .newsletter-wrapper, .newsletter-wrapper) :is(.newsletter-campaign:has(.response:not(:empty)), .newsletter-and-social:has(.response:not(:empty))){width:100%;}.newsletter-wrapper .newsletter_bar_col{display:flex;flex-wrap:wrap;justify-content:center;align-items:center;gap:8px 20px;margin:0 auto;}.newsletter-wrapper .newsletter_bar_col .text-element{display:flex;color:var(--shares-color);margin:0 !important;font-weight:400 !important;font-size:16px !important;}.newsletter-wrapper .newsletter_bar_col .whitebar_social{display:flex;gap:12px;width:auto;}.newsletter-wrapper .newsletter_bar_col a{margin:0;background-color:#0000;padding:0;width:32px;height:32px;}.newsletter-wrapper .social_icon:after{display:none;}.newsletter-wrapper .widget article:before, .newsletter-wrapper .widget article:after{display:none;}#sFollow_Block_0_0_1_0_0_0_1{margin:0;}.donation_banner{position:relative;background:#000;}.donation_banner .posts-custom *, .donation_banner .posts-custom :after, .donation_banner .posts-custom :before{margin:0;}.donation_banner .posts-custom .widget{position:absolute;inset:0;}.donation_banner__wrapper{position:relative;z-index:2;pointer-events:none;}.donation_banner .donate_btn{position:relative;z-index:2;}#sSHARED_-_Support_Block_0_0_7_0_0_3_1_0{color:#fff;}#sSHARED_-_Support_Block_0_0_7_0_0_3_1_1{font-weight:normal;}.grey_newsblock .newsletter-wrapper, .newsletter-wrapper, .newsletter-wrapper.sidebar{background:linear-gradient(91deg, #005dc7 28%, #1d63b2 65%, #0353ae 85%);}
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
"When it comes to the DOJ's proposal to reschedule marijuana, public opinion could not be clearer," said a campaigner with Drug Policy Alliance, which analyzed public comments on the pending change.
Shortly after the public comment period for the Biden administration's proposed rule to reschedule marijuana closed, a reform group on Tuesday released an analysis showing that the majority of submissions advocate for federal decriminalization.
When President Joe Biden pardoned U.S. citizens and lawful permanent residents convicted of simple federal marijuana possession in October 2022, he also ordered the departments of Justice (DOJ) and Health and Human Services to review how cannabis is treated under the Controlled Substances Act.
Marijuana is currently Schedule I, the federal law's most restrictive category, despite dozens of states allowing adult recreational or medicinal use. In May, the Drug Enforcement Administration (DEA), which is part of the DOJ, proposed a shift to Schedule III and initiated the public comment period that ended Monday.
"Participation in public comment processes gives the American public a chance to speak from personal experience and provide feedback on proposed legal changes—and it gives the federal government an opportunity to adjust their proposals to reflect public opinion," said Cat Packer of the Drug Policy Alliance (DPA), which reviewed submissions.
"When it comes to the DOJ's proposal to reschedule marijuana, public opinion could not be clearer," added Packer, DPA's director of drug markets and legal regulation. "Rescheduling is simply not enough."
As DPA detailed in a statement, after analyzing the 42,910 public comments, the group found:
"The people are demanding the Biden administration do more to deliver on the marijuana reforms that communities deserve," Packer said, pointing to previous promises from Biden and Vice President Kamala Harris, the presumptive Democratic nominee to face former Republican President Donald Trump and U.S. Sen. JD Vance (R-Ohio) in the November election.
Packer highlighted that nearly half of the comments "recognize that ending federal criminalization is key to achieving racial justice and social equity," and "this is something that the Biden administration has repeatedly identified as a priority in their marijuana reform efforts."
"However, under Schedule III, communities of color would still face disproportionate harms and lifelong consequences from federal marijuana criminalization," she explained. "Under Schedule III, people could still be jailed or deported for marijuana violations, even in states where it is legal. Under Schedule III, people could lose their jobs, their housing, their... food stamp benefits, or even lose custody of their children for marijuana violations."
Earlier this month, DPA and Human Rights Watch released a 91-page report detailing how the U.S. War on Drugs has impacted the lives of immigrants, "punishing people with deep connections to the United States, where they have formed families, attained education, and built their lives."
Packer argued Tuesday that "if the Biden administration wants to be responsive to public opinion and live up to their own stated values of racial justice and repair, marijuana must be federally decriminalized and additional actions must be taken to end the lifelong collateral consequences that result from marijuana criminalization."
"This is a galvanizing moment for our movement for drug policies grounded in health, equity, and reinvestment," she stressed. "Even if marijuana is ultimately rescheduled through this process, there are additional actions that President Biden and Congress can take. In the coming weeks and months, we will continue working with our allies to urge President Biden to take a whole government approach to advance equity in federal marijuana policy and mitigate the harms of criminalization."
"That means expanding pardons and commutations, protecting state marijuana programs, and directing federal agencies to cease punishing people for marijuana use," she said. "We know that the people and the evidence are on our side. It is time that our federal government listened."
Despite support from top figures including Senate Majority Leader Chuck Schumer (D-N.Y.), there is little hope that the current divided Congress would decriminalize marijuana. As Marijuana Momentreported shortly before House Speaker Mike Johnson (R-La.) was voted into his role last year, he "has consistently voted against cannabis-related legislation."
The cannabis industry analytics firm Headset on Tuesday also reviewed public submissions for the new proposal and noted that "this comment period has shattered previous DEA records, surpassing even the highly contentious 2020 telemedicine rules that garnered approximately 38,000 comments."
"To put this into perspective, that's roughly equivalent to the entire population of Juneau, the capital city of Alaska," the firm highlighted. "It's as if every resident of a small state capital took the time to voice their opinion on this crucial issue."
Headset found that 92.45% of comments were in favor of changing cannabis' schedule, with 61.7% of them advocating for descheduling and 38.3% supporting a shift to a less restrictive category. Just 7.55% wanted to retain Schedule I.
"Those supporting rescheduling emphasized potential medical benefits, increased research opportunities, and alignment with state laws," Headset said. "Proponents of descheduling, the largest group, advocated for complete legalization, citing social justice concerns, economic opportunities, and personal liberty."
The decision "validates the experiences of tens of millions of Americans, as well as tens of thousands of physicians, who have long recognized that cannabis possesses legitimate medical utility," said one advocate.
As Democratic lawmakers push for the federal decriminalization of marijuana, U.S. President Joe Biden on Thursday announced the Department of Justice was formalizing a proposal to remove the substance from Schedule I—the legal classification which for decades has placed marijuana in the same category as heroin.
The Drug Enforcement Administration's (DEA) proposal to reschedule marijuana under Schedule III—which would place it alongside substances like testosterone and steroids—was submitted as a Notice of Formal Rulemaking in the Federal Register, commencing a 60-day public comment period.
After the comment period and any public hearings that are requested by interested parties, the DEA is expected to issue a final order on reclassifying marijuana.
In a video message posted to social media, Biden called the step his administration has taken "monumental" and said marijuana's current classification suggests it is more dangerous than "fentanyl and methamphetamine—the two drugs driving America's overdose epidemic."
"That just doesn't add up," said the president. "Today's announcement builds on the work we've done to pardon a record number of federal offenses for simple possession of marijuana, and it adds to the action we've taken to lift barriers to housing, employment, small business loans, and so much more for tens of thousands of Americans."
"Far too many lives have been upended because of a failed approach to marijuana and I'm committed to righting those wrongs," added Biden.
With marijuana classified under Schedule III, the federal government would for the first time officially acknowledge the medical benefits of the substance, which is approved for medical use in 43 U.S. states and territories as well as the District of Columbia.
Federal scientists will be able to research the medical benefits of the drug for the first time since 1971, when the Controlled Substances Act placed marijuana under Schedule I.
The new classification could also eliminate tax burdens for legal cannabis businesses.
Paul Armentano, deputy director of the National Organization for the Reform of Marijuana Laws (NORML), said Biden's decision "validates the experiences of tens of millions of Americans, as well as tens of thousands of physicians, who have long recognized that cannabis possesses legitimate medical utility."
"As a first step forward, this policy change dramatically shifts the political debate surrounding cannabis," Armentano added. "Specifically, it delegitimizes many of the tropes historically exploited by opponents of marijuana policy reform. Claims that cannabis poses unique harms to health, or that it's not useful for treating chronic pain and other ailments, have now been rejected by the very federal agencies that formerly perpetuated them. Going forward, these specious allegations should be absent from any serious conversations surrounding cannabis and how to best regulate its use."
Biden's announcement came a week after Senate Majority Leader Chuck Schumer (D-N.Y.) was joined by 17 other Democratic senators in reintroducing S. 4226, the Cannabis Administration and Opportunity Act (CAOA), which would remove marijuana from the Controlled Substances Act and allow states to regulate the substance.
Schumer applauded the White House for "recognizing that draconian cannabis laws need to change to catch up to science and the majority of Americans," but said marijuana must now be decriminalized at the federal level.
"The proposed change fails to harmonize federal marijuana policy with the cannabis laws of most U.S. states," said Armentano, "particularly the 24 states that have legalized its use and sale to adults."
Sen. Cory Booker urged fellow lawmakers to "follow the lead of states around the country and legalize cannabis for adult use and create a comprehensive taxation and regulatory scheme."
U.S. marijuana legalization advocates greeted Tuesday's news that the Drug Enforcement Administration is proposing rescheduling cannabis to a less restrictive class by calling on President Joe Biden to fully deschedule the plant, which is approved for recreational or medicinal use in the vast majority of states.
The Associated Pressreported the DEA is proposing rescheduling marijuana from Schedule I—which includes heroin, MDMA, and LSD—to Schedule III, a far less restrictive class that includes ketamine, anabolic steroids, testosterone, and over-the-counter products containing less than 90 milligrams of codeine per dose. According to the DEA, Schedule I drugs have "no currently accepted medical use and a high potential for abuse."
While it would not legalize cannabis for recreational use, the DEA proposal—which is subject to review by the White House Office of Management and Budget—would affirm medicinal marijuana and recognize that the plant has a lower potential for abuse than other widely used recreational drugs.
The Drug Policy Alliance (DPA)—which works to end the failed 53-year War on Drugs—warned that "under this proposed shift, marijuana criminalization would continue at the federal level and most penalties, including those for simple possession, would continue as long as marijuana remains anywhere on the Controlled Substances Act (CSA)."
While running for president in 2020, Biden repeatedly vowed to decriminalize marijuana and expunge the criminal records of people convicted of cannabis possession. In 2022 the president issued a "full, complete, and unconditional pardon to all current United States citizens and lawful permanent residents" convicted of simple federal marijuana possession—a move that affected thousands of people but excluded those who are in the United States without authorization.
The following year, Health and Human Services (HHS) Secretary Xavier Becerra confirmed that his department would recommend rescheduling cannabis to Schedule III.
Sen. Cory Booker (D-N.J.) on Tuesday urged Congress to "follow the lead of states around the country and legalize cannabis for adult use and create a comprehensive taxation and regulatory scheme."
"Thousands of people remain in prisons around the country for marijuana-related crimes. Thousands of people continue to bear the devastating collateral consequences that come with a criminal record," the senator continued. "Legal marijuana businesses, especially those in communities hardest hit by the War on Drugs, still have to navigate a convoluted patchwork of state laws and regulatory schemes."
"I hope that my colleagues on both sides of the aisle, especially those who represent constituents benefiting from medical or adult-use programs, join me to pass federal legislation to fix these problems," Booker added.
Senate Majority Leader Chuck Schumer (D-N.Y.) said that "it is great news that DEA is finally recognizing that restrictive and draconian cannabis laws need to change to catch up to what science and the majority of Americans have said loud and clear."
"While this rescheduling announcement is a historic step forward, I remain strongly committed to continuing to work on legislation like the SAFER Banking Act as well as the Cannabis Administration and Opportunity Act, which federally deschedules cannabis by removing it from the Controlled Substances Act," he added.
Booker and Schumer were among the 21 senators who last week sent a letter to U.S. Attorney General Merrick Garland and DEA Administrator Anne Milgram noting that it's been 18 months since Biden ordered HHS October to review cannabis scheduling and eight months since the agency's rescheduling recommendation.
"While we understand that the DEA may be navigating internal disagreement on this matter, it is critical that the agency swiftly correct marijuana's misguided placement in Schedule I," the letter states.
Legalization advocates, meanwhile, pushed the Biden administration to go much further, as 24 states plus the District of Columbia have approved adult-use recreational marijuana and 38 states have legalized medicinal cannabis.
"Supporting federal marijuana decriminalization means supporting the removal of marijuana from the Controlled Substances Act, not changing its scheduling," DPA director of drug markets and legal regulation Cat Packer said in a statement. "We all deserve a federal framework for marijuana that upholds the health, well-being, and safety of our communities—particularly Black communities who have borne the brunt of our country's racist enforcement of marijuana laws."
"Rescheduling marijuana is not a policy solution for federal marijuana criminalization or its harms, and it won't address the disproportionate impact that it has had on Black and Brown communities," Packer added.
Dasheeda Dawson, chair of the Cannabis Regulators of Color Coalition and founder of Cannabis NYC, said: "The time for descheduling cannabis is not just a matter of policy; it's an imperative for justice and equity. Rescheduling would undermine the hard-fought progress made by cannabis equity and policy reform leaders like the Cannabis Regulators of Color Coalition, jeopardizing the livelihoods and futures of those entrepreneurs and communities disproportionately affected by past criminalization."
"We cannot afford to backtrack on our commitment to repair the harm inflicted by outdated policies," Dawson added. "Descheduling is not just about legality; it's about rectifying historic injustices and ensuring a fair and inclusive future for all."